Medical devices, healthcare technology and the business of care
510(k) clearance · K261245

Restrata

Acera Surgical, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK261245

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Restrata, a traditional 510(k) submitted by Acera Surgical, Inc. of St. Louis, Missouri, under number K261245. The decision date is October 16, 2026, and the application was received April 16, 2026. The device falls under the classification name Absorbable Synthetic Wound Dressing with product code QSZ, and the review panel was General & Plastic Surgery. SESE denotes clearance of the 510(k), not premarket approval.

The October 16, 2026 letter describes Restrata as a sterile, single-use device intended for use in the management of wounds, and notes it may be used with the V.A.C. ULTA Negative Pressure Wound Therapy System. The record does not include the specialty field, the predicate device, or the summary of the technological comparison, so the basis for the equivalence finding is not established here. No efficacy or patient-outcome conclusions are drawn.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Oct 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261245
Regulatory pathway
510(k) premarket notification
Product code
QSZ
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Absorbable Synthetic Wound Dressing.

Product code
QSZ
FDA device class
U

FDA decision timeline

  1. K261245 received

    Application receipt date recorded by FDA.

  2. K261245 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QSZ

Product / regulatory recordCompanyPathwayDecision dateSource
Anika Therapeutics, Inc.510(k) clearanceSep 2, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Acera Surgical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
St. Louis, MO

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records